Search earnings tickers

REGN

2024Q4BMO

Regeneron Pharmaceuticals Inc primary · HEALTHCARE · BIOTECHNOLOGY

Report 2025-02-04 · Fiscal end 2024-12-31 · Features as of 2025-02-03

← Earnings history

Street

Consensus EPS11.19

Consensus rev—

EPS high—

EPS low—

Dispersion—

Analysts—

EPS rev net 7d—

EPS rev net 30d—

Consensus Δ 7d—

Consensus Δ 30d—

Options

Implied move2.2%

IV front—

P/C full—

P/C front—

Features as of2025-02-03

Run-up

Close—

Ret 5d-2.6%

Ret 10d-2.2%

Ret 20d-6.8%

Ret 30d-9.9%

Print

Actual EPS

12.07Beat

Estimated EPS11.19

Actual revenue

3.8B

Surprise %+7.9%

Beat / missBeat

Beat streak 43

Beat streak 83

Reaction

1-day stock reaction+7.2%

Implied vs actual

Implied 2.2%Actual 2.5%

Gap reaction-2.5%

Day result+4.5%

Next-day upYes

Realized / IV1.16×

Post tape

Post 5d-4.5%

Post 10d-1.6%

Post volume1.7M

Vol ×10d1.80×

Vol ×20d1.81×

Post range10.5%